Timothy C. Dec - Feb 22, 2025 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
Senior Vice-President & CFO
Signature
/s/ Timothy C. Dec
Stock symbol
SUPN
Transactions as of
Feb 22, 2025
Transactions value $
$0
Form type
4
Date filed
2/24/2025, 08:16 PM
Previous filing
Feb 21, 2025
Next filing
Mar 4, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Award $0 +500 +6.18% $0.00 8.59K Feb 22, 2025 Direct
transaction SUPN Common Stock Award $0 +3K +34.92% $0.00 11.6K Feb 22, 2025 Direct
transaction SUPN Common Stock Award $0 +2.5K +21.57% $0.00 14.1K Feb 23, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Restricted Stock Unit Disposed to Issuer $0 -500 -50% $0.00 500 Feb 22, 2025 Common Stock 500 Direct F1, F2
transaction SUPN Restricted Stock Unit Disposed to Issuer $0 -3K -25% $0.00 9K Feb 22, 2025 Common Stock 3K Direct F1, F3
transaction SUPN Restricted Stock Unit Disposed to Issuer $0 -2.5K -33.33% $0.00 5K Feb 23, 2025 Common Stock 2.5K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
F2 These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023.
F3 These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025.
F4 These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024.